4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide (Venetoclax)
This compound is a complex intermediate in pharmaceutical synthesis, specifically related to antihistamine or anti-inflammatory agents. The structure features a chlorophenyl-cyclohexene moiety linked via piperazine to a nitro-substituted aromatic ring. Molecular Formula: C28H30ClN5O4. CAS No.: 1079-66-1 (Note: Exact CAS may vary based on specific salt form; verify with supplier). Core production involves multi-step organic synthesis including Friedel-Crafts alkylation and nucleophilic substitution.
Handle with strict adherence to safety data sheets due to potential mutagenicity of nitro groups. Store in cool, dry conditions away from light and incompatible oxidizers. Personnel must utilize appropriate PPE including respirators and chemical-resistant gloves during handling.